Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
13.63
+0.30 (2.25%)
Jan 21, 2026, 2:52 PM EST - Market open
Amneal Pharmaceuticals Market Cap
Amneal Pharmaceuticals has a market cap or net worth of $4.28 billion as of January 21, 2026. Its market cap has increased by 78.21% in one year.
Market Cap
4.28B
Enterprise Value
6.72B
1-Year Change
78.21%
Ranking
Category
Stock Price
$13.63
Market Cap Chart
Since May 7, 2018, Amneal Pharmaceuticals's market cap has increased from $1.91B to $4.28B, an increase of 124.73%. That is a compound annual growth rate of 11.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 4.19B | 5.79% |
| Dec 31, 2025 | 3.96B | 61.41% |
| Dec 31, 2024 | 2.45B | 31.88% |
| Dec 29, 2023 | 1.86B | 517.28% |
| Dec 30, 2022 | 301.44M | -57.87% |
| Dec 31, 2021 | 715.49M | 6.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 7, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hims & Hers Health | 6.94B |
| Alkermes | 5.24B |
| Lantheus Holdings | 4.37B |
| Indivior | 4.11B |
| Prestige Consumer Healthcare | 3.11B |
| Kiniksa Pharmaceuticals International, | 3.11B |
| Supernus Pharmaceuticals | 2.86B |
| HUTCHMED (China) | 2.60B |